Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, May 10, 2023
[ Wed, May 10th 2023
] - WOPRAI
[ Wed, May 10th 2023
] - WOPRAI
[ Wed, May 10th 2023
] - WOPRAI
[ Wed, May 10th 2023
] - WOPRAI
[ Wed, May 10th 2023
] - WOPRAI
[ Wed, May 10th 2023
] - WOPRAI
[ Wed, May 10th 2023
] - WOPRAI
[ Wed, May 10th 2023
] - WOPRAI
[ Wed, May 10th 2023
] - WOPRAI
[ Wed, May 10th 2023
] - WOPRAI
[ Wed, May 10th 2023
] - WOPRAI
[ Wed, May 10th 2023
] - WOPRAI
[ Wed, May 10th 2023
] - WOPRAI
[ Wed, May 10th 2023
] - WOPRAI
[ Wed, May 10th 2023
] - WOPRAI
Tue, May 9, 2023
[ Tue, May 09th 2023
] - WOPRAI
[ Tue, May 09th 2023
] - WOPRAI
[ Tue, May 09th 2023
] - WOPRAI
[ Tue, May 09th 2023
] - WOPRAI
[ Tue, May 09th 2023
] - WOPRAI
[ Tue, May 09th 2023
] - WOPRAI
[ Tue, May 09th 2023
] - WOPRAI
[ Tue, May 09th 2023
] - WOPRAI
[ Tue, May 09th 2023
] - WOPRAI
[ Tue, May 09th 2023
] - WOPRAI
[ Tue, May 09th 2023
] - WOPRAI
[ Tue, May 09th 2023
] - WOPRAI
[ Tue, May 09th 2023
] - WOPRAI
[ Tue, May 09th 2023
] - WOPRAI
[ Tue, May 09th 2023
] - WOPRAI
Matthew Biegler Reiterated (APTO) at Buy and Held Target at $135 on, May 9th, 2023
Matthew Biegler of Oppenheimer, Reiterated "Aptose Biosciences Inc." (APTO) at Buy and Held Target at $135 on, May 9th, 2023.
Matthew has made no other calls on APTO in the last 4 months.
There is 1 other peer that has a rating on APTO. Out of the 1 peers that are also analyzing APTO, 0 agree with Matthew's Rating of Hold.
This is the rating of the analyst that currently disagrees with Matthew
- Carey Macrury of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $120 on, Monday, March 27th, 2023
